ENTITY

Medigene AG (MDG1 GR)

Analysis

Health Care • Germany

Medigene AG operates as a biopharmaceutical company. The Company provides research, development, and commercialization of drugs for the treatment of cancer and autoimmune diseases.

Refresh

No events found

We’ll display events we find for Medigene AG here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00